Endoplasmic reticulum (ER) News and Research

RSS

Medicare, uninsured, elderly and critically ill patients use ambulances for transport to ER: Study

Patients with Medicare or Medicaid, the uninsured, the elderly and the critically ill are the heaviest users of ambulances for transport to the emergency department, making them most vulnerable during periods of ambulance diversion. The results of a study of more than 30,000 patients taken to emergency departments by ambulance were published online Friday in Annals of Emergency Medicine ("At-Risk Populations and the Critically Ill Rely Disproportionately on Ambulance Transport to Emergency Departments").

14 Jun 2010

New guideline to improve IHC testing for expression status of ER and PgR in breast cancer issued

The College of American Pathologists and the American Society of Clinical Oncology today issued a joint guideline aimed at improving the accuracy of immunohistochemistry testing for the expression status of estrogen and progesterone receptors in breast cancer. The two groups conducted a systematic review of medical research literature in partnership with Cancer Care Ontario to develop the recommendations.

14 Jun 2010

Impax reaches agreement with Endo and Penwest to settle pending litigation for OPANA ER

Impax Laboratories, Inc. today announced that it has reached agreement with Endo Pharmaceuticals and Penwest Pharmaceuticals to settle pending U.S. litigation with regard to the production and sale of generic formulations of OPANA ER (oxymorphone hydrochloride) Extended Release tablets.

9 Jun 2010

Endo, Penwest announce settlement of OPANA ER litigation with Impax

Endo Pharmaceuticals and Penwest Pharmaceuticals announced today that the companies have settled litigation with Impax Laboratories, Inc. regarding the production and sale of generic formulations of OPANA® ER (oxymorphone hydrochloride) Extended Release tablets.

9 Jun 2010

Top 10 tips to avoid medical mistakes

In this new original and eye-opening book, THE NOT SO PATIENT ADVOCATE: How To Get The Healthcare You Need Without Fear Or Frustration, readers walk through the seemingly forbidden or secretive door to the mystifying and occasionally infuriating maze that is today's healthcare machine. The author shares candid facts about what actually goes on where healthcare interaction occurs.

8 Jun 2010

bioTheranostics presents positive outcomes from CancerTYPE ID, Breast Cancer Index clinical studies

bioTheranostics, a bioMerieux company that develops innovative oncology diagnostic tests to drive personalized treatment, reported today findings from clinical studies utilizing the company's CancerTYPE ID® and Breast Cancer Index® molecular oncology tests. Data from the studies were presented this week at the American Society of Clinical Oncology (ASCO) 2010 Annual Meeting in Chicago.

7 Jun 2010

Positive results from Phase 2, open-label ENCORE 303 trial to be presented at ASCO 2010

Syndax Pharmaceuticals, Inc., a clinical-stage epigenetics oncology company, reported final results from the Phase 2, open-label ENCORE 303 trial in post-menopausal women with advanced, estrogen receptor positive breast cancer who were progressing on aromatase inhibitor therapy.

5 Jun 2010

Labopharm comments on the outcome of patent-infringement litigation related to Ultram ER

Labopharm Inc. today commented on the outcome of the appeal by Purdue Pharma Products L.P. and the cross-appeal by Par Pharmaceutical Companies, Inc. of the decision of the United States District Court for the District of Delaware in August 2009 on patent-infringement litigation initiated by Purdue against Par relating to Ultram ER (tramadol hydrochloride extended-release tablets).

4 Jun 2010

NHO introduces first healthcare assistance program for Americans, employers, groups and associations

National Health Options announces the first healthcare assistance program of its kind designed to offer an affordable, accessible, and comprehensive solution for Americans, employers, groups and associations -- including an estimated 47 million people who are underinsured or unemployed. NHO provides access to high quality healthcare products and services that can improve individual health and welfare.

2 Jun 2010

911 program aims to reduce ER visits

USA Today reports on a 911 pilot program that aims to reduce unnecessary trips to the emergency rooms.

2 Jun 2010

Anthem launches new "modernized" Medicare Supplement plans

Today Anthem Blue Cross and Blue Shield in Maine (Anthem) introduced new "modernized" Medicare Supplement plans that have been updated to consider the needs of today's Medicare beneficiaries.

29 May 2010

2010 Southeast Michigan Mid-Market Group Benefits Survey released

McGraw Wentworth, Michigan's largest employee group benefit brokerage/consulting firm, today released the results of its 2010 Southeast Michigan Mid-Market Group Benefits Survey. The annual survey, now in its seventh year, tracks health benefits and trends for 2010 among 414 southeast Michigan organizations with 100-10,000 employees.

24 May 2010

Most ER visitors have health insurance of some kind

A National Center for Health Statistics study has found that of the one in five Americans who visit an emergency room every year, most have health insurance.

20 May 2010

First Edition: May 20, 2010

Today's news includes the lastest developments regarding the Medicare pay fix and continuing analysis regarding how health reform votes will play into the 2010 electoral landscape.

20 May 2010

Allergy sufferers can save out-of-pocket costs by visiting urgent care and retail health clinics instead of ER

In this economy, allergy sufferers are looking for relief from more than sneezing, runny noses, and itchy eyes. And, according to a recent study, they can find relief for both their symptoms and their wallets, saving anywhere from $50 to $400 in out-of-pocket costs per visit if they skip the emergency room and head to urgent care and retail health clinics when they are unable to see their primary physician.

20 May 2010

Study identifies suppression as a mediator between negative emotions and desire to binge

A German study published in the current issue of Psychotherapy and Psychosomatics explores what is behind binge eating.

19 May 2010

Human Pheromone Sciences first-quarter net revenues increase 12% to $185,000

Human Pheromone Sciences, Inc. today announced results for the first quarter ended March 31, 2010. Net revenues of $185,000 represented a 12% increase from the revenues of $165,000 in the prior year period, and resulted in a net loss of $98,000 ($.02 per share) as compared with net loss of $181,000 ($.04 per share) for the same period in 2009.

15 May 2010

FDA grants tentative approval for Impax Laboratories' generic Opana ER

Impax Laboratories, Inc. today confirmed that the U.S. Food and Drug Administration (FDA) has granted tentative approval of the Company's Abbreviated New Drug Application (ANDA) for generic version of Opana® ER (oxymorphone hydrochloride) 5, 7.5, 10, 15, 20, 30 and 40 mg tablets.

14 May 2010

Measuring gene expression in healthy women may predict future breast cancer risk, say scientists

Researchers at Georgetown Lombard Comprehensive Cancer Center have been able to show, in mice, how just a little adjustment in the expression of two common genes can promote the kind of cellular changes that led to breast cancer. They say these tweaks likely mimic natural variation women have in expression of the two genes.

14 May 2010

Health reform implementation issues: Emergency room costs, consumer websites and small business questions

Kaiser Health News: The new health reform law guarantees insurance companies must cover emergency care for their beneficiaries at hospitals in- or out-of-network at the same rate. "The law also bars health plans from requiring prior authorization for emergency services. And it mandates that plans follow the 'prudent layperson' rule.

14 May 2010

Endoplasmic reticulum (ER) News and Research

Medicare, uninsured, elderly and critically ill patients use ambulances for transport to ER: Study

New guideline to improve IHC testing for expression status of ER and PgR in breast cancer issued

Impax reaches agreement with Endo and Penwest to settle pending litigation for OPANA ER

Endo, Penwest announce settlement of OPANA ER litigation with Impax

Top 10 tips to avoid medical mistakes

bioTheranostics presents positive outcomes from CancerTYPE ID, Breast Cancer Index clinical studies

Positive results from Phase 2, open-label ENCORE 303 trial to be presented at ASCO 2010

Labopharm comments on the outcome of patent-infringement litigation related to Ultram ER

NHO introduces first healthcare assistance program for Americans, employers, groups and associations

911 program aims to reduce ER visits

Anthem launches new "modernized" Medicare Supplement plans

2010 Southeast Michigan Mid-Market Group Benefits Survey released

Most ER visitors have health insurance of some kind

First Edition: May 20, 2010

Allergy sufferers can save out-of-pocket costs by visiting urgent care and retail health clinics instead of ER

Study identifies suppression as a mediator between negative emotions and desire to binge

Human Pheromone Sciences first-quarter net revenues increase 12% to $185,000

FDA grants tentative approval for Impax Laboratories' generic Opana ER

Measuring gene expression in healthy women may predict future breast cancer risk, say scientists

Health reform implementation issues: Emergency room costs, consumer websites and small business questions

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News